Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1987 1
1989 1
1991 7
1992 9
1993 10
1994 20
1995 18
1996 10
1997 12
1998 14
1999 4
2000 6
2001 4
2002 1
2003 5
2004 3
2005 11
2006 9
2007 5
2008 5
2009 7
2010 9
2011 9
2012 4
2013 10
2014 7
2015 9
2016 16
2017 10
2018 4
2019 7
2020 10
2021 13
2022 20
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

263 results
Results by year
Filters applied: . Clear all
Page 1
Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Pliskin M, Beahrs JR, Prall D, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Tadros NN, Gange SN, Roehrborn CG. McVary KT, et al. J Urol. 2021 Sep;206(3):715-724. doi: 10.1097/JU.0000000000001778. Epub 2021 Apr 19. J Urol. 2021. PMID: 33872051 Clinical Trial.
PURPOSE: We present final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor therapy (Rezum) for treatment of moderate to severe lower urinary tract symptoms due to benign prostatic hyperplasia. MATERIALS AND METHODS: A total …
PURPOSE: We present final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor therapy (Rezum) for treatment …
Nononcologic Embolization.
De la Garza-Ramos C, Salei A, Caridi TM. De la Garza-Ramos C, et al. Semin Intervent Radiol. 2022 Nov 17;39(4):416-420. doi: 10.1055/s-0042-1758077. eCollection 2022 Aug. Semin Intervent Radiol. 2022. PMID: 36406022 Review.
Apart from oncologic indications, embolization is used to treat a wide range of benign pathology, including uterine fibroids and benign prostatic hyperplasia. While various particulate embolic agents are successfully used for benign embolization …
Apart from oncologic indications, embolization is used to treat a wide range of benign pathology, including uterine fibroids and b …
MRI Evaluation of Patients Before and After Interventions for Benign Prostatic Hyperplasia: An Update.
Diaz TA, Benson B, Clinkenbeard A, Long JR, Kawashima A, Yano M. Diaz TA, et al. AJR Am J Roentgenol. 2022 Jan;218(1):88-99. doi: 10.2214/AJR.21.26278. Epub 2021 Jul 14. AJR Am J Roentgenol. 2022. PMID: 34259037 Review.
Transurethral resection of the prostate is the most commonly performed procedure for the management of patients with lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH). However, in recent years, various minimally invasive surgical t …
Transurethral resection of the prostate is the most commonly performed procedure for the management of patients with lower urinary tract sym …
Benign Prostatic Hyperplasia Implications for Pharmacologic Treatment and Perioperative Care.
Leedahl DD, Vo PH, Maxson PM, Lovely JK. Leedahl DD, et al. J Pharm Pract. 2013 Feb;26(1):52-8. doi: 10.1177/0897190012451913. Epub 2012 Jul 13. J Pharm Pract. 2013. PMID: 22797835 Review.
This review provides an update on the treatment of benign prostatic hyperplasia and the pharmacologic considerations for perioperative care. By age 85 years, approximately 90% of men have prostate histologic characteristics consistent with benign pr …
This review provides an update on the treatment of benign prostatic hyperplasia and the pharmacologic considerations fo …
Benign prostatic hyperplasia. Its natural history, epidemiologic characteristics, and surgical treatment.
Oesterling JE. Oesterling JE. Arch Fam Med. 1992 Nov;1(2):257-66. doi: 10.1001/archfami.1.2.257. Arch Fam Med. 1992. PMID: 1285243 Review.
Benign prostatic hyperplasia is a nonmalignant enlargement of the prostate that is due to both epithelial and stromal hyperplasia. ...This clinical report provides a comprehensive review of the natural history, epidemiologic characteristics, and outcom …
Benign prostatic hyperplasia is a nonmalignant enlargement of the prostate that is due to both epithelial and stromal …
ACR Appropriateness Criteria® Lower Urinary Tract Symptoms-Suspicion of Benign Prostatic Hyperplasia.
Expert Panel on Urological Imaging; Alexander LF, Oto A, Allen BC, Akin O, Chong J, Froemming AT, Fulgham PF, Goldfarb S, Maranchie JK, Mody RN, Patel BN, Schieda N, Schuster DM, Turkbey IB, Venkatesan AM, Wang CL, Lockhart ME. Expert Panel on Urological Imaging, et al. J Am Coll Radiol. 2019 Nov;16(11S):S378-S383. doi: 10.1016/j.jacr.2019.05.031. J Am Coll Radiol. 2019. PMID: 31685105 Review.
Lower urinary tract symptoms due to benign prostatic enlargement have a high prevalence in men over 50 years of age. ...
Lower urinary tract symptoms due to benign prostatic enlargement have a high prevalence in men over 50 years of age. ...
Medical treatment of benign prostatic hyperplasia: 5 alpha-reductase inhibitors and alpha-adrenergic antagonists.
Monda JM, Oesterling JE. Monda JM, et al. Mayo Clin Proc. 1993 Jul;68(7):670-9. doi: 10.1016/s0025-6196(12)60603-x. Mayo Clin Proc. 1993. PMID: 7688840 Review.
Benign prostatic hyperplasia (BPH), a nonmalignant neoplasm of the prostatic epithelial and stromal tissue, occurs commonly in elderly men. ...In some patients, this outcome decreases the mechanical obstruction of the prostatic urethra and impro …
Benign prostatic hyperplasia (BPH), a nonmalignant neoplasm of the prostatic epithelial and stromal tissue, occu …
Acupuncture for benign prostatic hyperplasia: A systematic review and meta-analysis.
Zhang W, Ma L, Bauer BA, Liu Z, Lu Y. Zhang W, et al. PLoS One. 2017 Apr 4;12(4):e0174586. doi: 10.1371/journal.pone.0174586. eCollection 2017. PLoS One. 2017. PMID: 28376120 Free PMC article. Review.
PURPOSE: This systematic review and meta-analysis aims to assess the therapeutic and adverse effects of acupuncture for benign prostatic hyperplasia (BPH) in randomized controlled trials (RCTs). ...
PURPOSE: This systematic review and meta-analysis aims to assess the therapeutic and adverse effects of acupuncture for benign pro …
Benign prostatic hyperplasia: treat or wait?
Davidson JH, Chutka DS. Davidson JH, et al. J Fam Pract. 2008 Jul;57(7):454-63. J Fam Pract. 2008. PMID: 18625168 Review.
Rule out potential causes of lower urinary tract symptoms with a thorough medical history, focused physical exam (including digital rectal examination and neurological assessments), and appropriate laboratory evaluations. When choosing treatment for benign prostatic …
Rule out potential causes of lower urinary tract symptoms with a thorough medical history, focused physical exam (including digital rectal e …
Travel characteristics and outcomes for patients seeking HoLEP.
Narang G, Moore J, Abdul-Muhsin H, Cheney S, Humphreys M. Narang G, et al. Can J Urol. 2022 Apr;29(2):11067-11074. Can J Urol. 2022. PMID: 35429424
INTRODUCTION: Holmium laser enucleation of the prostate (HoLEP) is an effective but underutilized option for the surgical management of benign prostatic hyperplasia (BPH). With low adoption, questions arise surrounding patients access to care. ...
INTRODUCTION: Holmium laser enucleation of the prostate (HoLEP) is an effective but underutilized option for the surgical management of b …
263 results